Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be incredibly versatile, originally developed as a treatment for diabetes, and later used for treating obesity and promoting weight loss.
A recent 32-week, double-blind, placebo-controlled trial by TruDiagnostic suggests that Ozempic may reduce the user’s biologic age by just over three years.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
The positive impact on weight-management makes the drugs helpful in treating conditions associated or impacted by obesity.
Author's summary: Ozempic reduces biological age.
More News
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Australian government bans Dutch volleyball rapist
- Exclusive: CMYKhub opens the doors at new Keilor Park premises - Sprinter
- Environment and Sustainable Development 5 Minute F... | Clayton Utz
- Australia’s reduction roadmap calls for a 99 percent cut in new housing emissions
- In bid for UN Security Council, Philippines vows to uphold rule of law
- Belleville hikes parking fees by 50% for motorists in the new year
- Chevron Thailand and Digitas turn lubricant production into immersive roadside experience
- Victorian Access Regime: VicGrid’s new regime for ... | Clayton Utz